Pentwater Capital Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,200
| Closed | -$241K | – | 139 |
|
|
2022
Q1 | $241K | Sell |
1,200
-226
| -16% | -$45.4K | ﹤0.01% | 119 |
|
|
2021
Q4 | $311K | Buy |
1,426
+786
| +123% | +$171K | ﹤0.01% | 150 |
|
|
2021
Q3 | $292K | Buy |
640
+164
| +34% | +$74.8K | ﹤0.01% | 176 |
|
|
2021
Q2 | $191K | Hold |
476
| – | – | ﹤0.01% | 242 |
|
|
2021
Q1 | $276K | Hold |
476
| – | – | ﹤0.01% | 254 |
|
|
2020
Q4 | $271K | Hold |
476
| – | – | ﹤0.01% | 176 |
|
|
2020
Q3 | $266K | Hold |
476
| – | – | ﹤0.01% | 169 |
|
|
2020
Q2 | $270K | Buy |
+476
| New | +$270K | ﹤0.01% | 112 |
|